FDA Inspection
Pfizer Manufacturing Belgium NVPfizer Manufacturing Belgium NV – FDA Inspection, Jun 21, 2017
Record Details
This FDA Inspection record concerns Pfizer Manufacturing Belgium NV, with an inspection on June 21, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · d79fe448-660b-4824-b777-45f01e60193e
Inspection Facts
- Inspection number
- 1025434
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Pfizer Manufacturing Belgium NV
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2024 | Not classified | Office of Inspections and Investigations | |
| May 17, 2024 | Not classified | Office of Inspections and Investigations | |
| June 8, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 16, 2023 | Not classified | Office of Inspections and Investigations | |
| June 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Manufacturing Belgium NV
- FDA Inspection 1240714 - 2024-06-28
- FDA Inspection 1239799 - 2024-05-17
- FDA Inspection 1208904 - 2023-06-08
- FDA Inspection 1214848 - 2023-05-16
- FDA Inspection 1203291 - 2022-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.